Your address will show here +12 34 56 78
Partner News
No definite cure exists for Alzheimer’s disease yet, but promising drugs have emerged through the years that help stem its progress. However, these treatments must be administered early in the course of the illness for them to do any good. This race against time has pushed researchers to find other ways to tame this debilitating disease.

A lot of treatments have been developed to try to delay the onset of Alzheimer’s, but no commercially approved medication has been proven to dramatically and rapidly reduce the toxic buildup of the Alzheimer’s-causing proteins in the blood.

That is, until Amylex Biotech Corp. — a US-based biotechnology company — reported that it had developed a treatment that targeted the root cause of the disease in hopes of slowing it down. This innovation, according to its developer, will soon be available in the Philippines.

Betaclear

Called Betaclear, the treatment is designed to eliminate the buildup of harmful beta-amyloid toxins in the blood before they can disrupt the connection and proper functioning of brain cells. The process involved is “extracorporeal,” meaning, it takes place outside the body, so side effects are unlikely, Amylex claims.

One of the most sought-after objectives in the search for a potential cure for Alzheimer’s is reducing beta-amyloids, which are toxic protein fragments that collect in the blood and in “plaque” in the brain. Beta-amyloids have been linked to diabetes and Alzheimer’s.



Read more: https://newsinfo.inquirer.net/1077987/innovative-alzheimers-treatment-coming-to-ph-soon#ixzz5fsQrmxQy 
Follow us: @inquirerdotnet on Twitter | inquirerdotnet on Facebook
0